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Abstract: Pseudomonas aeruginosa has an ability to rapidly develop resistance to most antimicrobial compounds,
and to check this ability. The isolates were collected from different pathological human sources and tested for their
sensitivity to aminoglycoside antibiotic and to honey, a natural product that is generating renewed interest for its
therapeutic application using Kirby Bauer disc diffusion technique. Aminoglycoside antibiotic which is normally
active against gram-negative bacteria was used alongside honey. The 29 isolates of P. aeruginosa showed 100%
sensitivity to honey tested in their undiluted form. This was not the case with gentamicin (10µg) and amikacin (30
µg), both of which varied in their antipseudomonal activity, like even 1:2 aqueous dilution of honey appreciably
inhibited pseudomonal isolates than either of the two aminoglycoside antibiotic. Honey is therefore suggested as
an effective natural product in overcoming the widespread antibiotic resistance of P. aeruginosa.
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INTRODUCTION
Pseudomonas aeruginosa is an opportunistic pathogen
that causes urinary tract infections, respiratory system
infections, dermatitis, soft tissue infections, bacteremia
and a variety of systemic infections, particularly in victims
of severe burns, and in cancer and AIDS patients who
are immuno-suppressed (Cachia and Hodges, 2003). P.
aeruginosa is not particularly distinctive as a
pseudomonad, but there are a few characteristics that
are noteworthy and relate to its pathogenesis. P.
aeruginosa possesses the metabolic versatility for which
pseudomonads are so renowned. P. aeruginosa produces
two types of soluble pigments, pyocyanin and
(fluorescent)  pyoverdin.  The latter is produced
abundantly in media of low-iron content, and could
function in iron metabolism in the bacterium (Todar, 2004).
Pyocyanin (from “pyocyaneus”) refers to “blue pus”
which is a characteristic of suppurative infections caused
by P. aeruginosa. P. aeruginosa is notorious for its
resistance to antibiotics and is, therefore, a particularly
dangerous and dreaded pathogen. Comparatively in the
aminoglycosides, gentamicin, in combination with
vancomycin or penicillin, provides a good remedy, also
gentamicin was observed in an in vitro experiment to
effectively inhibit gram-negative bacterial infections
particularly P. aeruginosa ((Klika and Goodman,1982;
Osman et al., 2003). Similarly, honey was reported to be
effective against a wide range of medically important
bacteria and even higher fungi (Tysett et al., 1993, Molan,
1999).
Honey is produced from many floral sources and its
antimicrobial activity varies markedly with its origin and
processing (Willix et al., 1992; Cooper and Molan, 1999;
Cooper et al., 2002). This variation can be due to
difference in the enzymatic action and in the presence of
additional antibacterial components derived from the floral
source (Irish et al., 2011). Due to emergence of antibiotic
resistant strains, P. aeruginosa isolated from different
anatomical sites were evaluated for their antibacterial
action using honey and aminoglycosides.
MATERIALS AND METHODS
Twenty nine isolates of P. aeruginosa from various
pathological sources (Table 1) were obtained on sterile
nutrient agar (Hi-media) slants from hospitals in and
around Vapi area, Gujarat. They were re-isolated on king’s
agar and subjected to conventional tests (Cowan, 1974)
and then preserved on fresh nutrient agar slants in a
refrigerator at 40C. The honey used in the present study
was from Pardeshi babul and Neem forest of Kachchh
and Banaskantha districts, which was used in undiluted
form and also as 1:2 aqueous dilutions against each
isolates of P. aeruginosa. The aminoglycoside antibiotic
(Hi-media) was also used alongside honey against each
P. aeruginosa isolate.
The susceptibility pattern of each pseudomonal isolate
was obtained following the standard single disc diffusion
method developed by Bauer et al. (1966) against
undiluted honey and its 1:2 aq. dilution and
aminoglycoside. The results were interpreted according
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to the guidelines of the Clinical and Laboratory Standards
Institute (CLSI) and the organisms were scored as either
sensitive or resistant.
RESULTS
A total of 29 isolates were obtained from 300 clinical
samples collected from patients having pyogenic
infection, amongst the clinical isolates, 22 (75.9%) were
from ear swab, 4 (13.8%) from wound swab, 2 (6.9%) from
pus swab and 1 (3.4 %) from burn wound.
Screening for Multi Drug Resistant (MDR) isolates
showed that 27/29 (93%) isolates were MDR strains
showing resistance to at least 3 antibiotics and to third
generation cephalosporin. Antibiotic susceptibility
testing of the isolates showed varying degree of
sensitivity to the antibiotics tested. Highest resistance
was seen for tetracycline and cefuroxime (86.2%),
followed by clindamycin (75.9%) and ampicillin/
sulbactum (72.4%) (Fig. 1).
The undiluted honey (neat honey) used for each
pseudomonal isolate produced zones of growth inhibition
ranging from 14.4 to 25.4 mm, indicating 100% sensitivity
of all isolates of P. aeruginosa against neat honey.
However, gentamicin, amikacin and the 1.2 aq. dilutions
of the honey sample varied in their growth inhibition
(Table 2). In the honey sample, only one isolate failed to
be inhibited (3.4% resistance) by 1.2 aq. dilutions, while
Isolate Honey Gentamicin Amikacin 
Source 0 1:2 10 µg/ml 30 µg/ml 
Diameter of zone of inhibition (mm) 
Wound swab 15.7 10.1 11.4 14.4 
Ear swab 20.2 15.3 9.5 8.8 
Ear swab 17.0 11.0 9.7 9.2 
Ear swab 20.1 15.0 9.4 10.7 
Pus swab 14.4 10.4 11.9 11.9 
Ear swab 21.7 16.2 13.8 14.7 
Ear swab 22.5 13.2 14.5 13.1 
Ear swab 15.2 9.4 8.2 8.7 
Ear swab 16.4 - 11.8 7.9 
Ear swab 22.5 16.7 14.0 15.3 
Ear swab 23.7 13.3 14.9 14.0 
Ear swab 23.4 14.2 8.7 9.0 
Wound swab 21.4 10.0 5.5 6.6 
Ear swab 20.2 10.1 6.3 5.3 
Ear swab 17.3 9.4 - - 
Ear swab 16.7 9.2 8.7 7.7 
Wound swab 22.8 11.8 7.7 9.3 
Ear swab 24.0 17.2 9.4 9.4 
Ear swab 24.4 16.8 11.8 11.7 
Burn wound 22.9 13.6 12.0 13.6 
Ear swab 17.7 11.6 15.4 14.7 
Ear swab 19.6 12.6 6.9 7.6 
Ear swab 24.7 16.3 - 11.2 
Ear swab 25.4 15.7 16.8 11.7 
Wound swab 23.6 13.8 13.3 14.5 
Ear swab 22.4 14.9 13.4 9.1 
Ear swab 19.8 11.0 11.9 13.8 
Pus swab 19.8 10.8 7.7 - 
Ear swab 21.5 11.7 10.6 12.5 
 
Pathological source No. of isolates 
Wound swab 4 
Ear swab 22 
Burn wound  1 
Pus swab 2 
Table 1. Pathological sources of Pseudomonas aeruginosa.
Table 2. Antibacterial activity of honey and aminoglycoside against clinical isolates of P. aeruginosa.
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Fig 1. Antibiotic susceptibility pattern of P.aeruginosa isolated from various pathological source.
gentamicin and amikacin failed to inhibit 2 of the 29
isolates (6.9%) (Table 2).
DISCUSSION
P. aeruginosa has long been recognized as a major burn
pathogen and is the predominant cause of fatal burn
wound sepsis (Artz et al., 1969; Hummel et al., 1970;
Teplitz, 1979; Mohr et al., 2004). Interest has increased in
the alternative natural therapies with the isolation of
multidrug resistant strains, in that honey has received
renewed recognition as burn-wound healers. This natural
product was found to be individually effective against
bacteria, although the aminoglycoside used alongside
was reported to be that effective.
In the present study the results were in agreement with
the study of Tan et al. (2009) who reported that Indian
origin honey have the activity against P. aeruginosa
isolates compared to honey like Tualang and Manuka.
Lusby et al. (2005) also reported that local honey used
have the same antibactericidal activity as compared with
other pharmaceutical honeys, this is evident in the 100%
sensitivity of the pseudomonal isolates to the undiluted
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stock of the honey sample tested. This activity was also
shared by the 1:2 aq. dilution of the honey and gentamicin
(10 µg) and amikacin (30 µg) with a few numbers of
resistant isolates which is in partial agreement with
Adeleke et al. (2006). Richard et al. (1988) in his study
found that aminoglycoside particularly gentamicin and
amikacin showed no and little bactericidal activity
respectively against the isolates which is in partial
agreement with our study, whereas Basson and Grobler
(2008) found no such antimicrocidal activity in honey
from South Africa, the native place. It has been found
that honey is not only sound as a topical healing agent
but also has antibacterial and antifungal properties and
promotes wound healing with less scar formation
(Subrahmanyam et al., 2001; Osman et al., 2003). Notably,
the fact that the strains of P. aeruginosa tested came
from different human pathological sources lends credence
to honey’s therapeutic value.
Conclusion
In conclusion, honey a natural, non-toxic and inexpensive
product has the activity against P. aeruginosa isolated
from different human pathological sources indicating the
medicinal importance of Indian honey against these
isolates.
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